Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Phyton Acquires Glyco-Engineering Technique

  • Phyton Biotech acquired Dow Chemical’s technology and intellectual property platform for the engineering of glycosylation in pharmaceutical protein products.

    This transaction will be enhanced through a research collaboration with the Dutch research institute Plant Research International, part of Wageningen University & Research Centre and one of the innovators of the technology platform, according to Phyton.

    The Dow agreement coincides with the installation of a second 75,000-liter bioreactor at Phyton’s German cell fermentation facility.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.